Attorneys / Scott Cunning, Ii
SI
Attorney
Scott Cunning, Ii
Reg. No. 77,015Attorney·Parker Poe Adams & Bernstein, LLP
Washington, Washington, DC, US
Overview
22
Years experience
52
Matters · evidenced
8
ANDA cases
—
Ranking
Litigation & ANDA matters
52 evidenced matters. Showing 8 of 52.
| Case | Court | Type | Role |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc., et al | D. Del. | ANDA / Hatch-Waxman | Defendant |
| Crystal Pharmaceutical (Suzhou) Co., Ltd. v. Eisai Inc. | CAFC | CAFC | Appellant |
| Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd. | D. Del. | ANDA / Hatch-Waxman | Defendant |
| Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al | D. Del. | ANDA / Hatch-Waxman | Defendant |
| Neurocrine Biosciences, Inc. v. Lupin Limited et al | D. Del. | ANDA / Hatch-Waxman | Defendant |
| Eisai Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al. | PTAB | Type 4 | Defendant |
| Evergreen Theragnostics, Inc. v. Advanced Accelerator Applications SA | PTAB | Type 4 | Plaintiff |
| In re: Entresto (Sacubitril/Valsartan) Patent Litigation | D. Del. | ANDA / Hatch-Waxman | Notice Only |
More on file
Performance scores & rank, Practice areas, industries & languages are available with an account.
LinkedIn & external profile links is available with a subscription.